Research progress of neutrophil-mediated drug delivery strategies for inflammation-related disease
Y Zhao, H Zhang, Q Zhang, H Tao - Pharmaceutics, 2023 - mdpi.com
As the most abundant white blood cells in humans, neutrophils play a key role in acute and
chronic inflammation, suggesting that these cells are a key component of targeted therapies …
chronic inflammation, suggesting that these cells are a key component of targeted therapies …
Targeting and functional effects of biomaterials-based nanoagents for acute pancreatitis treatment
Y Cai, Q Cao, J Li, T Liu - Frontiers in Bioengineering and …, 2023 - frontiersin.org
Acute pancreatitis (AP) is a severe life-threatening inflammatory disease showing primary
characteristics of excessive inflammatory response and oxidative stress. Based on the …
characteristics of excessive inflammatory response and oxidative stress. Based on the …
Inflammation and Acinar Cell Dual-Targeting Nanomedicines for Synergistic Treatment of Acute Pancreatitis via Ca2+ Homeostasis Regulation and Pancreas …
Y Wang, X Wang, X Zhang, B Zhang, X Meng, D Qian… - ACS …, 2024 - ACS Publications
Severe acute pancreatitis (AP) is a life-threatening pancreatic inflammatory disease with a
high mortality rate (∼ 40%). Existing pharmaceutical therapies in development or in clinical …
high mortality rate (∼ 40%). Existing pharmaceutical therapies in development or in clinical …
Biomimetic Trypsin-Responsive Structure-Bridged Mesoporous Organosilica Nanomedicine for Precise Treatment of Acute Pancreatitis
Y Wang, D Qian, X Wang, X Zhang, Z Li, X Meng… - ACS …, 2024 - ACS Publications
Developing strategies to target injured pancreatic acinar cells (PACs) in conjunction with
primary pathophysiology-specific pharmacological therapy presents a challenge in the …
primary pathophysiology-specific pharmacological therapy presents a challenge in the …
Anti-PD-L1 checkpoint inhibitor combined with nanocarrier-mediated cisplatin codelivery system for effective treatment of pancreatic cancer
ZY Jia, X Yan, H Zhou, W Wang, C Li, BL Zhang - Molecular Immunology, 2024 - Elsevier
Immune checkpoint inhibitor-based cancer immunotherapy has shown promise as a
potential treatment in the clinic. It has been reported that anti-PD-L1 combined with cisplatin …
potential treatment in the clinic. It has been reported that anti-PD-L1 combined with cisplatin …
[HTML][HTML] Influence of standardized nursing intervention combined with mindfulness stress reduction training on the curative effect in patients with acute pancreatitis
S Li, D Yin, XC Guo - World Journal of Clinical Cases, 2023 - ncbi.nlm.nih.gov
BACKGROUND Acute pancreatitis (AP) is a common inflammatory disease of the pancreas
with high mortality rates. It is of great significance to take scientific intervention measures for …
with high mortality rates. It is of great significance to take scientific intervention measures for …
全胰切除术对胰腺肿瘤的近远期疗效分析
周文涛， 韩思阳， 徐天威， 匡天涛， 戎叶飞… - 肝胆胰外科 …, 2022 - gdy.qk.wmu.edu.cn
目的探讨全胰切除术(TP) 在胰腺肿瘤患者中的近远期疗效. 方法回顾性纳入2005 年6 月至2018
年3 月复旦大学附属中山医院43 例TP 患者, 分析其临床病理特征, 手术情况 …
年3 月复旦大学附属中山医院43 例TP 患者, 分析其临床病理特征, 手术情况 …
[PDF][PDF] 金属支架联合ERCP 及Spyglass 在幽门梗阻合并胰管结石中的应用
蒲唯高， 马晨辉， 王海云， 王云鹏， 张静， 何普毅… - 肝胆胰外科 …, 2022 - gdy.qk.wmu.edu.cn
目的探讨金属支架联合ERCP 及Spyglass 对幽门梗阻合并胰管结石(PDS)
治疗的有效性及安全性. 方法回顾性分析2021 年8 月15 日兰州大学第二医院1 …
治疗的有效性及安全性. 方法回顾性分析2021 年8 月15 日兰州大学第二医院1 …